Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Total Current Liabilities of $294.3 million for Q4 2025, down 24.13% year-over-year from $387.9 million in Q4 2024, and down 24.13% quarter-over-quarter from $387.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $294.3 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 24.13% year-over-year to $294.3 million; the TTM figure through Dec 2025 stood at $294.3 million (down 24.13% YoY), while the FY2025 annual figure was $294.3 million, down 24.13% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $294.3 million, down from $387.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $436.8 billion in Q1 2022, with the low at $215.3 million in Q2 2021.
- The 5-year median for Total Current Liabilities is $385.3 million (2022), against an average of $31.6 billion.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 183454.65% in 2022, then sank 31.81% in 2024.
- Curaleaf Holdings' Total Current Liabilities stood at $316.2 million in 2021, then jumped by 38.16% to $436.9 million in 2022, then climbed by 13.07% to $494.0 million in 2023, then retreated by 21.48% to $387.9 million in 2024, then retreated by 24.13% to $294.3 million in 2025.
- Business Quant data shows CURLF's Total Current Liabilities at $294.3 million in Q4 2025, $387.9 million in Q4 2024, and $379.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 307.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 307.11 Mn |
| Dec 31, 2025 | 294.31 Mn |
| Dec 31, 2024 | 387.93 Mn |
| Sep 30, 2024 | 379.26 Mn |
| Jun 30, 2024 | 392.51 Mn |
| Dec 31, 2023 | 494.03 Mn |
| Sep 30, 2023 | 556.21 Mn |
| Jun 30, 2023 | 515.88 Mn |
| Sep 30, 2022 | 436.92 Mn |
| Jun 30, 2022 | 382.65 Mn |
| Mar 31, 2022 | 436.81 Bn |
| Dec 31, 2021 | 316.24 Mn |
| Sep 30, 2021 | 335.21 Mn |
| Jun 30, 2021 | 215.35 Mn |
| Mar 31, 2021 | 237.97 Mn |
| Dec 31, 2020 | 220.13 Mn |
| Sep 30, 2020 | 177.15 Mn |
| Dec 31, 2019 | 106.26 Mn |